Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

The internet has accurate information on Polycystic Ovarian Syndrome, but it's not high quality or easy to read, so we need better, user-friendly resources.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The document concluded that home treatments are needed for hair loss control, but professionals should better understand how these treatments work.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Eating better, exercising, staying clean during periods, and learning about health can help reduce menstrual problems and improve life quality.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

People with a common type of hair loss have higher stress levels in their body, and treatments that reduce this stress could help.

The research found genes that change during cashmere goat hair growth and could help determine the best time to harvest cashmere.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

ECM changes may play a role in hair loss, with differences between males and females.

PCOS may increase the risk of mental health issues like depression and anxiety.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Endurance exercise may help BPH by lowering hormones and inflammation.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.